SEMA4D and Miyoshi myopathy: The mean Sema4D levels of the bone marrow plasma of the MM patients were dramatically elevated compared to controls (149 ng/ml ± 112 vs. 23 ± 12 ng/ml, p < 0.01, Fig. 3a).